Brookfield Business

BBUCNYSEUSD

THESIS ALERT

Email me when the BBUC thesis changes

Evidence-based analysis, not personalized investment advice. Every alert email carries an unsubscribe link.

Follow on X
$28.68
−$0.32 (−1.10%)Today 1M +7.38%
After hours$28.680.00%

Updated Nov 13, 4:00 PM ET · Regular session · May be delayed

Source valuation snapshot. Not a live recalculation.
Latest filed annual earnings; price snapshot date unavailable. Not forward P/E.
Diluted earnings per share from the latest filed annual.
$29.00
Prior regular-session close from the quote source.
$28.63–$29.58
Regular-session low and high so far today.
205.8K
Regular-session shares traded · Nov 13, 4:00 PM ET.
Not yet confirmed
The company has not confirmed its next report date. Reported quarters are available in the chart’s Earnings view.
$24.80–$38.25
52-week trading low and high returned by the quote source.

Understand the Business

Why the Stock Moved

Period-matched expectations history is not yet available. Current metrics are not a substitute for a historical explanation.

The core investment thesis

Own BBUC if Brookfield’s control-investing and asset-recycling machine turns complex operating businesses into cash and per-share value faster than leverage, minority claims, and portfolio churn consume the return.

BBUC price history

Latest price$28.68Today−$0.32 (-1.10%)
BBUC +9.91%S&P 500 -2.05%Since first plotted close
4 hours

Loading recent earnings…

Investment thesis

What must happen next

5 MATERIAL PROPOSITIONS
  • Brookfield’s active-control model continues to turn a changing portfolio into operating cash, so value creation is funded by owned businesses rather than by repeated equity issuance or forced asset sales.StrengtheningMateriality: High

    Annual IFRS operating_cash_flow was $3.23 billion in FY2025, roughly stable versus $3.281 billion in FY2024 despite much lower reported revenue. If this holds, BBUC can compound through cycles; if it breaks, the portfolio becomes dependent on capital markets instead of self-funding.

    Watch: Large controlled subsidiaries begin consuming cash because working capital reverses or customers delay payments in construction, services, or industrial operations.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    Annual IFRS operating_cash_flow was $3.23 billion in FY2025, roughly stable versus $3.281 billion in FY2024 despite much lower reported revenue.

    Open source ↗
  • Portfolio recycling remains disciplined: lower consolidated revenue reflects exits and mix changes rather than permanent impairment, and released capital is redeployed into higher-return controlled businesses.HoldingMateriality: High

    Annual IFRS revenue declined from $57.385 billion in FY2022 to $27.457 billion in FY2025, showing that reported revenue is heavily affected by portfolio composition rather than a simple same-store growth path. If true, revenue volatility is tolerable; if false, the company is shrinking its economic base while still carrying a complex cost and leverage structure.

    Watch: Brookfield is unable to sell mature holdings at acceptable valuations because strategic buyers and private-equity buyers pull back.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    Annual IFRS revenue declined from $57.385 billion in FY2022 to $27.457 billion in FY2025, showing that reported revenue is heavily.

    Open source ↗
  • Brookfield’s asset-level financing discipline protects optionality, so leverage does not force distressed sales before operational improvements and exits can mature.HoldingMateriality: Medium

    Annual IFRS liabilities declined from $70.821 billion at FY2022 to $60.45 billion at FY2025. If financing remains controlled, Brookfield can wait for better exit windows; if not, lenders rather than owners determine timing and value realization.

    Watch: A refinancing wall at portfolio companies forces asset sales in weak markets.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    Annual IFRS liabilities declined from $70.821 billion at FY2022 to $60.45 billion at FY2025.

    Open source ↗
  • The BBUC/BBU structure must deliver economics to exchangeable shareholders; consolidated profit is not enough if minority interests, preferred claims, fees, or exchange dynamics absorb value before diluted EPS.WeakeningMateriality: Medium

    Annual IFRS eps_diluted was negative $0.30 in FY2025 even though annual IFRS net_income was positive at $387 million. If common holders do not receive the economics, even good portfolio outcomes can fail to compound BBUC per-share value.

    Watch: Noncontrolling interests, preferred distributions, incentive arrangements, or other claims continue to leave little earnings for BBUC common shareholders.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    Annual IFRS eps_diluted was negative $0.30 in FY2025 even though annual IFRS net_income was positive at $387 million.

    Open source ↗
  • The asset base has to remain monetizable at or above carrying values; otherwise Brookfield’s deal-selection edge is not creating durable value, it is carrying assets whose equity value is eroding.HoldingMateriality: Medium

    Annual IFRS equity remained positive at $15.311 billion at FY2025. If carrying values are realizable, future exits can crystallize value; if not, write-downs and below-book sales reduce owner equity and credibility.

    Watch: Audited impairments appear in major holdings, especially in cyclical industrial, construction, or services assets.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    Annual IFRS equity remained positive at $15.311 billion at FY2025.

    Open source ↗
Full investment case & evidence

Loading the original research archive…

Original research

Brookfield’s active-control model continues to turn a changing portfolio into operating cash, so value creation is funded by owned businesses rather than by repeated equity issuance or forced asset sales. If this holds, BBUC can compound through cycles; if it breaks, the portfolio becomes dependent on capital markets instead of self-funding.

Portfolio recycling remains disciplined: lower consolidated revenue reflects exits and mix changes rather than permanent impairment, and released capital is redeployed into higher-return controlled businesses. If true, revenue volatility is tolerable; if false, the company is shrinking its economic base while still carrying a complex cost and leverage structure.

Brookfield’s asset-level financing discipline protects optionality, so leverage does not force distressed sales before operational improvements and exits can mature. If financing remains controlled, Brookfield can wait for better exit windows; if not, lenders rather than owners determine timing and value realization.

The BBUC/BBU structure must deliver economics to exchangeable shareholders; consolidated profit is not enough if minority interests, preferred claims, fees, or exchange dynamics absorb value before diluted EPS. If common holders do not receive the economics, even good portfolio outcomes can fail to compound BBUC per-share value.

The asset base has to remain monetizable at or above carrying values; otherwise Brookfield’s deal-selection edge is not creating durable value, it is carrying assets whose equity value is eroding. If carrying values are realizable, future exits can crystallize value; if not, write-downs and below-book sales reduce owner equity and credibility.

All standing thesis claims
Original report summary

Brookfield’s control-investing and asset-recycling machine turns complex operating businesses into cash and per-share value faster than leverage, minority claims, and portfolio churn consume the return.

Evidence assessed Nov 13, 2026. Expand each conclusion for its evidence and what would change it. Thesis evidence—not a buy or sell recommendation.

Bull case and bear case

Bull case and bear case for Brookfield Business

Where the evidence on Brookfield Business disagrees: Mixed on the latest evidence (Nov 13, 2026). Of its 5 thesis points, 1 strengthening, 3 holding and 1 weakening.

Bull case: what the evidence supports

  • Brookfield’s active-control model continues to turn a changing portfolio into operating cash, so value creation is funded by owned businesses rather than by repeated equity issuance or forced asset sales.

    sec.gov ↗

  • Portfolio recycling remains disciplined: lower consolidated revenue reflects exits and mix changes rather than permanent impairment, and released capital is redeployed into higher-return controlled businesses.

    sec.gov ↗

  • Brookfield’s asset-level financing discipline protects optionality, so leverage does not force distressed sales before operational improvements and exits can mature.

    sec.gov ↗

  • The asset base has to remain monetizable at or above carrying values; otherwise Brookfield’s deal-selection edge is not creating durable value, it is carrying assets whose equity value is eroding.

    sec.gov ↗

Bear case: what the evidence questions

  • The BBUC/BBU structure must deliver economics to exchangeable shareholders; consolidated profit is not enough if minority interests, preferred claims, fees, or exchange dynamics absorb value before diluted EPS.

    sec.gov ↗

Thesis-Break Engine

Thesis-break watch · Brookfield Business

12 mo agonow
Trailing daily price. No thesis break has crossed here, so there is no break base rate to project.

OptimistFi is watching Brookfield Business. No break-condition checks are on record yet — they accumulate as new filings are checked.

How the Thesis-Break Engine works →Historical outcomes are measured against the market after past breaks of the same kind, across all companies. Not a prediction.

MARKET + FINANCIAL SNAPSHOT

The numbers behind the thesis

Sourced from filings and market data

What Changed

  1. Mixed
    Foreign issuer material report (6-K).

    Brookfield Business filed an SEC report on 2026-11-13: Foreign issuer material report (6-K). It is a dated development that tests the current thesis.

  2. Mixed
    Foreign issuer material report (6-K).

    Brookfield Business filed an SEC report on 2026-11-05: Foreign issuer material report (6-K). It is a dated development that tests the current thesis.

  3. Mixed
    Foreign issuer material report (6-K).

    Brookfield Business filed an SEC report on 2026-08-14: Foreign issuer material report (6-K). It is a dated development that tests the current thesis.

Risks / falsifiers

What could break the thesis

  • Large controlled subsidiaries begin consuming cash because working capital reverses or customers delay payments in construction, services, or industrial operations.
  • Brookfield is unable to sell mature holdings at acceptable valuations because strategic buyers and private-equity buyers pull back.
  • A refinancing wall at portfolio companies forces asset sales in weak markets.
  • Noncontrolling interests, preferred distributions, incentive arrangements, or other claims continue to leave little earnings for BBUC common shareholders.
  • Audited impairments appear in major holdings, especially in cyclical industrial, construction, or services assets.

BBUC news

Loading headlines…

Financial statements

BBUC income statement

Annual filed results · USD · Oldest to newest. Margins are calculated from the reported figures.

BBUC: quick answers

What is BBUC's short interest?
As of October 30, 2026, 2.9M BBUC shares were sold short, up 1.5% from the count before. At the stock's average daily volume that is 8.8 days to cover. FINRA publishes the count twice a month. BBUC short interest history
ScoutJUST THIS STORY

LET’S MAKE THIS USEFUL · 1 OF 5

How would you like me to explain this?

Tell me what you want from this read. Start with a quick note, then adjust the details. Your other stories stay as they are.

We’ll remember your view of this story. The published article stays unchanged.

THIS STORY’S READING VIEWStandard · The whole picture

Clear explanations with context. Both sides of the evidence.